Table 1 Characteristics of buprenorphine-prescribing physicians and their practices reported as mean (standard deviation) or percentage (count)
From: A mixed methods study of HIV-related services in buprenorphine treatment
| Mean (SD) or % (N) | 95% CI | N | |
|---|---|---|---|
| Medical Specialty | 1149 | ||
| Addiction specialty (medicine or psychiatry) | 21.6% (248) | 19.2–24.0 | |
| Psychiatry (i.e., adult and/or child psychiatry with no mention of addiction) | 27.2% (312) | 24.6–29.7 | |
| All others (e.g., family medicine, internal medicine, primary care, emergency medicine) | 51.3% (589) | 48.4–54.2 | |
| Practice Settings | |||
| Individual medical practice | 50.8% (587) | 47.9–53.7 | 1155 |
| Group medical practice | 35.2% (406) | 32.4–37.9 | 1155 |
| Veterans Administration medical center (VAMC) | 4.6% (53) | 3.4–5.8 | 1155 |
| Hospital (non-VAMC) | 13.2% (152) | 11.2–15.1 | 1155 |
| Opioid treatment program (OTP dispensing methadone) | 6.2% (71) | 4.8–7.5 | 1155 |
| Non-OTP substance use disorder treatment program | 13.9% (161) | 11.9–15.9 | 1155 |
| Caseload Characteristics | |||
| Percentage of past-year patients with heroin use disorder (but not prescription opioids) | 23.5 (22.4) | 22.2–24.8 | 1135 |
| Percentage of past-year patients with prescription opioid use disorder (but not heroin) | 54.5 (27.3) | 52.9–56.1 | 1134 |
| Percentage of past-year patients with co-occurring heroin and prescription opioid use disorder | 22.8 (19.9) | 21.6–23.9 | 1133 |
| Physician Characteristics | |||
| Age | 55.5 (11.4) | 54.8–56.1 | 1160 |
| Female | 22.9% (267) | 20.5–25.3 | 1165 |
| Race and ethnicity | 1148 | ||
| White | 76.5% (878) | 74.0–78.9 | |
| Asian American | 12.5% (144) | 10.6–14.5 | |
| African American/Black | 4.7% (54) | 3.5–5.9 | |
| Hispanic/Latino | 4.4% (50) | 3.2–5.5 | |
| All others | 1.9% (22) | 1.1–2.7 | |
| Waivered to treat up to 100 patients | 57.8% (678) | 54.9–60.6 | 1174 |
